A possible link between iron deficiency and gastrointestinal carcinogenesis

Nutrition and Cancer

Volumn 61, Issue 4, 2009, Pages 415-426

  Pra, Daniel ^a,b,c   Rech Franke, Silvia Isabel ^d   Pegas Henriques, Joao Antonio ^b,e,f   Fenech, Michael ^c  

^a CATHOLIC UNIVERSITY OF PELOTAS   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c CSIRO   (Australia)

^d UNIVERSITY OF SANTA CRUZ DO SUL   (Brazil)

^e UNIVERSITY OF CAXIAS DO SUL   (Brazil)

^f UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C OXIDASE; CYTOCHROME P450; FERRITIN; IRON; TRANSFERRIN;

ANEMIA; APOPTOSIS; ATROPHIC GASTRITIS; CANCER EPIDEMIOLOGY; CANCER IMMUNIZATION; CANCER MODEL; CANCER RISK; CARCINOGENESIS; CELL METABOLISM; CIGARETTE SMOKING; COLON CARCINOMA; COLON TUMOR; COLORECTAL CANCER; DIGESTIVE SYSTEM CANCER; DNA DAMAGE; DNA REPAIR; DNA SYNTHESIS; DUODENUM TUMOR; DYSPHAGIA; ESOPHAGEAL ADENOCARCINOMA; FERRITIN BLOOD LEVEL; GASTRITIS; HOMEOSTASIS; HUMAN; INTESTINE METAPLASIA; IRON DEFICIENCY; IRON INTAKE; IRON METABOLISM; IRON OVERLOAD; IRON STORAGE; LARYNX CANCER; MOUTH CANCER; MOUTH CARCINOMA; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; OXYGEN SENSING; PRECANCER; RECTUM CARCINOMA; REVIEW; SQUAMOUS CELL CARCINOMA; STOMACH ADENOCARCINOMA; STOMACH CANCER; STOMACH HEMORRHAGE; TRANSFERRIN BLOOD LEVEL; TUMOR GROWTH;

ANEMIA, IRON-DEFICIENCY; ANIMALS; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; DNA DAMAGE; DNA REPAIR; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; IRON; IRON OVERLOAD; MALE; NUTRITIONAL STATUS; OXIDATIVE STRESS; PLUMMER-VINSON SYNDROME; STOMACH NEOPLASMS; XENOBIOTICS;

RODENTIA;

EID: 70449686530     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580902803701     Document Type: Review

References (129)

1. Toyokuni S: Iron-induced carcinogenesis: the role of redox regulation. Free Radical Biol Med 20, 553-566, 1996.
2. Ahn YS, Park RM, et al.: Cancer morbidity in iron and steel workers in Korea. Am J Ind Med 49, 647-657, 2006.
3. Valko M, Morris H, et al.: Metals, toxicity and oxidative stress. Curr Med Chem 12, 1161-1208, 2005.
4. Garry S, Nesslany F, et al.: Hematite (Fe2O3) acts by oxydative stress and potentiates benzo[a]pyrene genotoxicity. Chem Biol Interact 563, 117-129, 2004.
5. Franke SIR, Pŕa D, et al.: Influence of orange juice in the levels and in the genotoxicity of iron and copper. Food Chem Toxicol 44, 425-435, 2006.
6. Pŕa D, Franke SIR, Giulian R, Yoneama ML, Dias JF, et al.: Genotoxicity and mutagenicity of iron and copper in mice. BioMetals 21, 289-297, 2007.
7. Norat T, Lukanova A, et al.:Meat consumption and colorectal cancer risk: dose-response meta-analysis of epidemiological studies. Int J Cancer 98, 241-256, 2002.
8. Lee DH, Anderson KE, et al.: Heme iron, zinc, alcohol consumption, and colon cancer: Iowa Women's Health Study. J Natl Cancer Inst 96, 403-407, 2004.
9. Senesse P, Meance S, et al.: High dietary iron and copper and risk of colorectal cancer: a case-control study in Burgundy, France. Nutr Cancer 49, 66-71, 2004.
10. Lee DH, Anderson KE, et al.: Heme iron, zinc and upper digestive tract cancer: The Iowa Women's Health Study. Int J Cancer 117, 643-647, 2005.
11. Kabat GC, Miller AB, et al.: Dietary iron and heme iron intake and risk of breast cancer: a prospective cohort study. Cancer Epidemiol Biomarkers Prev 16, 1306-1308, 2007.
12. Institute of Medicine: Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Molybdenum, Nickel, Sillicon, Vanadium, and Zinc. Food and Nutrition Board. Washington, DC: National Academy Press, 2001.
13. Glei M, Klenow S, et al.: Hemoglobin and hemin induce DNA damage in human colon tumor cells HT29 clone 19A and in primary human colonocytes. Chem Biol Interact 594, 162-171.
14. Gray JI and Morton ID: Some toxic compounds produced in food by cooking and processing. J Hum Nutr 35, 5-23, 1981.
15. Hatch FT, Knize MG, et al.: Cooked-food mutagen reference list and index. Environ Mol Mutagen 12, 1-85, 1988.
16. Mainous AG III, Gill JM, et al.: Transferrin saturation, dietary iron intake, and risk of cancer. Ann Fam Med 3, 131-137, 2005.
17. Knekt P, Reunanen A, et al.: Body iron stores and risk of cancer. Int J Cancer 56, 379-382, 1994.
18. Herrinton LJ, Friedman GD, et al.: Transferrin saturation and risk of cancer. Am J Epidemiol 142, 692-698, 1995.
19. Nelson RL: Iron and colorectal cancer risk: human studies. Nutr Rev 59, 140-148, 2001.
20. Deneo-Pellegrini H, De Stefani E, et al.: Dietary iron and cancer of the rectum: a case-control study in Uruguay. Euro J Cancer Prev 8, 501-508, 1999. (Pubitemid 30019689)
21. Kuvibidila SR, Gauthier T, et al.: Serum ferritin levels and transferrin saturation in men with prostate cancer. J Nat Med Assoc 96, 641-649, 2004.
22. Hercberg S, Estaquio C, et al.: Iron status and risk of cancers in the SU.VI.MAX cohort. J Nutr 135, 2664-2668, 2005.
23. Bird CL, Witte JS, et al.: Plasma ferritin, iron intake, and the risk of colorectal polyps. Am J Epidemiol 144, 34-41, 1996.
24. Umbreit J: Iron deficiency: a concise review. Am J Hematol 78, 225-231, 2005.
25. Beard JL: Iron biology in immune function, muscle metabolism and neuronal functioning. J Nutr 131, 568S-579S, 580S, 2001.
26. Ortiz E, Pasquini JM, et al.: Effect of manipulation of iron storage, transport, or availability on myelin composition and brain iron content in three different animal models. J Neurosci Res 77, 681-689, 2004.
27. Arredondo M and Nunez MT: Iron and copper metabolism. Mol Aspects Med 26, 313-327, 2005.
28. Macdougall LG: Red cell metabolism in iron deficiency anemia: III. The relationship between glutathione peroxidase, catalase, serum vitamin E, and susceptibility of iron-deficient red cells to oxidative hemolysis. J Pediatr 80, 775-782, 1972.
29. Acharya J, Punchard NA, et al.: Red-cell lipid-peroxidation and antioxidant enzymes in iron-deficiency. Eur J Haematol 47, 287-291, 1991.
30. Knutson MD, Walter PB, et al.: Both iron deficiency and daily iron supplements increase lipid peroxidation in rats. J Nutr 130, 621-628, 2000.
31. Trost LB, Bergfeld WF, et al.: The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. J Am Acad Dermatol 54, 824-844, 2006.
32. Koziol JA, Ho NJ, et al.: Reference centiles for serum ferritin and percentage of transferrin saturation, with application to mutations of the HFE gene. Clin Chem 47, 1804-1810, 2001.
33. Wu TJ, Sempos CT, et al.: Serum iron, copper and zinc concentrations and risk of cancer mortality in US adults. Ann Epidemiol 14, 195-201, 2004.
34. McLaren CE, Gordeuk VR, et al.: Bivariate mixture modeling of transferrin saturation and serum ferritin concentration in Asians, African Americans, Hispanics, and whites in the Hemochromatosis and Iron Overload Screening (HEIRS) Study. Transl Res 151, 97-109, 2008.
35. Van Tits LJH, Jacobs EMG, et al.:Non-transferrin-bound iron is associated with plasma level of soluble intercellular adhesion molecule-1 but not with in vivo low-density lipoprotein oxidation. Atherosclerosis 194, 272-278, 2007.
36. Beutler E: Iron storage disease: facts, fiction and progress. Blood Cells Mol Dis 39, 140-147, 2007.
37. WHO: Guidelines for the control of iron deficiency in countries of the eastern Mediterranean Middle East and North Africa (Doc. WHOEM/ NUT/177, E/G/11.96/1000). Verster A ed. Regional Office for the Eastern Mediterranean, Cairo, Egypt.
38. Sempos CT: Iron and colorectal cancer. Nutr Rev 59, 344-346, 2001.
39. Paterson DR: A clinical type of dysphagia. J Laryngol Otol 34, 289-291.
40. Kelly AB: Spasm at the entrance of the oesophagus. J Laryngol Otol 34, 285-289, 1919.
41. Kim KH, Kim MC, et al.: Gastric cancer occurring in a patient with Plummer-Vinson syndrome: a case report. World J Gastroenterol 11, 7048-7050, 2005.
42. Jacobs A: The effect of iron deficiency on the tissues. Gerontol Clin (Basel) 13, 61-68, 1971.
43. Jacobs A: Non-haematological effects of iron deficiency. Clin Haematol 11, 353-364, 1982.
44. Larsson L-G, Sandstron A, et al.:Relationship of Plummer-Vinson Disease to cancer of the upper alimentary tract in Sweden. Cancer Res 35(Pt 2), 3308-3316, 1975.
45. Benjelloun A, Essakhraoui S, et al.: Plummer-Vinson syndrome in children. A report of three cases. Semaine Des Hopitaux 75, 74-77, 1999.
46. Mansell NJ, Jani P, et al.: Plummer-Vinson syndrome-a rare presentation in a child. J Laryngol Otol 113, 475-476, 1999.
47. Jessner W, Vogelsang H, et al. Plummer-Vinson syndrome associated with celiac disease and complicated by postcricoid carcinoma and carcinoma of the tongue. Am J Gastroenterol 98, 1208-1209.
48. Hoffman RMand Jaffe PE: Plummer-Vinson syndrome. A case report and literature review. Arch Intern Med 155, 2008-2011, 1995.
49. Vitale JJ, Broitman SA, et al. The effects of iron deficiency and the quality and quantity of fat on chemically induced cancer. Adv Exp Med Biol 91, 229-242, 1977.
50. Pillai KG and Burde KN: Increased copper level in oral mucosal tissue of submucous fibrosis patients chewing areca nut products. West Ind Med J 53, 35-36, 2004.
51. Dedon PC and Tannenbaum SR: Reactive nitrogen species in the chemical biology of inflammation. Arch Biochem Biophys 423, 12-22.
52. Miranda AL and Dantas RO: Esophageal contractions and oropharyngeal and esophageal transits in patients with iron deficiency anemia. Am J Gastroenterol 98, 1000-1004, 2003.
53. Atamna H, Liu J, et al.: Heme deficiency selectively interrupts assembly of mitochondrial complex IV in human fibroblasts: relevance to aging. J Biol Chem 276, 48410-48416, 2001.
54. Walter PB, Knutson MD, et al.: Iron deficiency and iron excess damage mitochondria and mitochondrial DNA in rats. Proc Natl Acad Sci USA 99, 2264-2269, 2002.
55. Atamna H: Heme, iron, and the mitochondrial decay of ageing. Ageing Res Rev 3, 303-318, 2004.
56. Mohandas KM, Swaroop VS, et al.: Upper esophageal webs, irondeficiency anemia, and esophageal cancer. Am J Gastroenterol 86, 117-118, 1991.
57. Gore RM: Esophageal cancer-clinical and pathologic features. Radiol Clin North Am 35, 243-263, 1997.
58. Chisholm M: The association between webs, iron, and post-cricoid carcinoma. Postgrad Med J 50, 215-219.
59. Zhang ZF, Kurtz RC, et al.: Adenocarcinomas of the esophagus and gastric cardia: the role of diet. Nutr Cancer 27, 298-309, 1997.
60. Gupta PC, Hebert JR, et al.: Influence of dietary factors on oral precancerous lesions in a population-based case-control study in Kerala, India. Cancer 85, 1885-1893, 1999.
61. Hebert, JR, Gupta PC, et al.: Dietary exposures and oral precancerous lesions in Srikakulam District, Andhra Pradesh, India. Pub Health Nutr 5, 303-312, 2002.
62. Akiba S, Neriishi K, et al.: Serum ferritin and stomach-cancer risk among a Japanese population. Cancer 67, 1707-1712, 1991.
63. Nomura A, Chyou PH, et al.: Association of serum ferritin levels with the risk of stomach cancer. Cancer Epidemiol Biomarkers Prev 1, 547-550, 1992.
64. Kato I, Dnistrian AM, et al.: Iron intake, body iron stores and colorectal cancer risk in women: A nested case-control study. Int J Cancer 80, 693-698, 1999. (Pubitemid 29066280)
65. Ioannou GN, Rockey DC, et al.: Iron deficiency and gastrointestinal malignancy: a population-based cohort study. Am JMed 113, 276-280, 2002.
66. Harrison LE, Zhang ZF, et al.: The role of dietary factors in the intestinal and diffuse histologic subtypes of gastric adenocarcinoma: a case-control study in the U.S. Cancer 80, 1021-1028, 1997.
67. Broitman SA, Velez H, et al.: A possible role of iron deficiency in gastric cancer in Colombia. Adv Exp Med Biol 135, 155-181, 1981.
68. Cross AJ, Gunter MJ, et al.: Iron and colorectal cancer risk in the alphatocopherol, beta-carotene cancer prevention study. Int J Cancer 118, 3147-3152, 2006.
69. Benzie IF: Evolution of dietary antioxidants. Comp Biochem Physiol A Mol Integr Physiol 136, 113-126, 2003.
70. Ali MA, AkhmedkhanovA, et al.:Reliability of serum iron, ferritin, nitrite, and association with risk of renal cancer in women. Cancer Detect Prev 27, 116-121, 2003.
71. Lorenzi M, Lorenzi B, et al.: Serum ferritin in colorectal cancer patients and its prognostic evaluation. Int J Biol Markers 21, 235-241, 2006.
72. Tseng M, Sandler RS, et al.: Dietary iron and recurrence of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 6, 1029-1032, 1997.
73. Rai S and Hemingway D: Iron deficiency anaemia-useful diagnostic tool for right sided colon cancers? Colorectal Dis 7, 588-590, 2005.
74. Joosten E, GhesquiereB, et al.:Upper and lower gastrointestinal evaluation of elderly inpatients who are iron deficient. Am J Med 107, 24-29, 1999.
75. Prime SS, Macdonald DG, et al.: The effect of iron-deficiency on experimental oral carcinogenesis in the rat. Br J Cancer 47, 413-418, 1983.
76. Jagadeesan V, Rao N. J, et al.: Effect of iron deficiency on DMH-induced gastrointestinal tract tumors and occurrence of hepatocyte abnormalities in Fischer rats. Nutr Cancer 22, 285-291, 1994.
77. Atamna HD and Killilea W, et al.: Heme deficiency may be a factor in the mitochondrial and neuronal decay of aging. PNAS 99, 14807-14812, 2002.
78. Riedl SJ and Salvesen GS: The apoptosome: signalling platform of cell death. Natl Rev Mol Cell Biol 8, 405-413, 2007.
79. Kempe DS, Lang PA, et al.: Enhanced programmed cell death of irondeficient erythrocytes. FASEB J 05-4872fje.
80. Berrak SG, Angaji M, et al.: The effects of iron deficiency on neutrophil/ monocyte apoptosis in children. Cell Prolif 40, 741-754, 2007.
81. Atamna H, Walter PB, et al.: The role of heme and iron-sulfur clusters in mitochondrial biogenesis, maintenance, and decay with age. Arch Biochem Biophys 397, 345-353, 2002.
82. Aslan M, Horoz M, et al.: Lymphocyte DNA damage and oxidative stress in patients with iron deficiency anemia. Chem Biol Interact 601, 144-149, 2006.
83. Strand KR, Karlsen S, et al.: Crystal structural studies of changes in the native dinuclear iron center of ribonucleotide reductase protein R2 from mouse. J Biol Chem 279, 46794-146784, 2004.
84. Al-Jam'a AH, Al-Dabbous IA, et al.: Are we underestimating the leukemogenic risk of hydroxyurea. Saudi Med J 23, 1411-1413, 2002.
85. Le Fevre A-C, Boitier E, et al.: Characterization of DNA reactive and non-DNA reactive anticancer drugs by gene expression profiling. Chem Biol Interact 619, 16-29, 2007.
86. Thompson JR, Gerald PF, et al.: Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukaemia in childhood: a case-control study. Lancet 358, 1935-1940, 2001.
87. Wen WQ, Shu XO, et al. Parental medication use and risk of childhood acute lymphoblastic leukemia. Cancer 95, 1786-1794, 2002.
88. Schuz J,Weihkopf T, et al.: Medication use during pregnancy and the risk of childhood cancer in the offspring. Eur J Pediatr 166, 433-441, 2007.
89. Brzoska K, Meczynska S, et al.: Iron-sulfur cluster proteins: electron transfer and beyond. Acta Biochim Pol 53, 685-691, 2006.
90. Fortini P, Pascucci B, et al.: The base excision repair: mechanisms and its relevance for cancer susceptibility. Biochimie 85, 1053-1071, 2003.
91. Mishina Y and He C: Oxidative dealkylation DNA repair mediated by the mononuclear non-heme iron AlkB proteins. J Inorgan Biochem 100, 670-678.
92. David SS, O'Shea VL, et al.: Base-excision repair of oxidative DNA damage. Nature 447, 941-950, 2007.
93. Pugh RA, Honda M, et al.: The iron-containing domain is essential in Rad3 helicases for coupling of ATP hydrolysis to DNA translocation and for targeting the helicase to the single-stranded DNA-double-stranded DNA junction. J Biol Chem 283, 1732-1743, 2008.
94. Mihaylova VT, Bindra RS, et al.: Decreased expression of the DNA mismatch repair gene Mlh1 under hypoxic stress in mammalian cells. Mol Cell Biol 23, 3265-3273, 2003.
95. Schafmayer C, Buch S, et al.: Genetic investigation of DNA-repair pathway genes PMS2, MLH1, MSH2, MSH6, MUTYH, OGG1 and MTH1 in sporadic colon cancer. Int J Cancer 121, 555-558.
96. Jansson LT, PerkkioMV, et al.: Red cell superoxide dismutase is increased in iron deficiency anemia. Acta Haematol 74, 218-221, 1985.
97. Kurtoglu E, Ugur A, et al.: Effect of iron supplementation on oxidative stress and antioxidant status in iron-deficiency anemia. Biol Trace Elem Res 96, 117-123, 2003. (Pubitemid 38130498)
98. Halliwell B, Zhao K, et al.: The gastrointestinal tract: a major site of antioxidant action? Free Radical Res 33, 819-830, 2000.
99. Thukkani AK, Albert CJ, et al.: Myeloperoxidase-derived reactive chlorinating species from human monocytes target plasmalogens in low density lipoprotein. J Biol Chem 278, 36365-36372, 2003.
100. Wu W, Samoszuk MK, et al.: Eosinophils generate brominating oxidants in allergen-induced asthma. J Clin Invest 105, 1455-1463, 2000.
101. Lanza F: Clinical manifestation ofmyeloperoxidase deficiency.JMol Med 76, 676-681, 1998.
102. Goth L and Vitai M: Hypocatalasemia in hospital patients. Clin Chem 42, 341-342.
103. Chen X, Liang H, et al.: Catalase transgenic mice: characterization and sensitivity to oxidative stress. Arch Biochem Biophys 422, 197-210, 2004.
104. Goldblatt MI, Choi S-H, et al.: Iron deficiency suppresses ileal nitric oxide synthase activity. J Gastrointest Surg 5, 393-400, 2001.
105. Harhaji L, Vuckovic O, et al.: Iron down-regulates macrophage antitumour activity by blocking nitric oxide production. Clin Exp Immunol 137, 109-116, 2004.
106. Ding XX and Kaminsky LS: Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu Rev Pharmacol Toxicol 43, 149-173, 2003.
107. Dhur A, Galan P, et al.: Effects of different degrees of iron deficiency on cytochrome P450 complex and pentose phosphate pathway dehydrogenases in the rat. J Nutr 119, 40-47, 1989.
108. Rao NJ and Jagadeesan V Effect of long term iron deficiency on the activities of hepatic and extra-hepatic drug metabolising enzymes in Fischer rats. Comp Biochem Physiol B Biochem Mol Biol 110, 167-173, 1995.
109. Bertrand G: On the role of trace substances in agriculture. Eight Int Congr Appl Chem 28, 30-40, 1912.
110. Raubenheimer DK, Lee P, et al.: Does Bertrand's relu apply to macronutriens? Proc Biol Sci 227, 2429-2434, 2005.
111. Fenech M: Recommended dietary allowances (RDAs) for genomic stability. Chem Biol Interact 480-481, 51-54, 2001.
112. Ames BN: The metabolic tune-up: metabolic harmony and disease prevention. J Nutr 133(5 Suppl 1), 1544S-1548S, 2003.
113. Fenech M: The Genome Health Clinic and Genome Health Nutrigenomics concepts: diagnosis and nutritional treatment of genome and epigenome damage on an individual basis. Mutagenesis 20, 255-269, 2005.
114. Fenech M, Baghurst P, et al.: Low intake of calcium, folate, nicotinic acid, vitamin E, retinol, beta-carotene and high intake of pantothenic acid, biotin and riboflavin are significantly associated with increased genome instability-results from a dietary intake and micronucleus index survey in South Australia. Carcinogenesis 26, 991-999, 2005.
115. Harris RP, Helfand M, et al.: Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med 20(3 Suppl), 21-35, 2001.
116. World Cancer Research and the American Institute for Cancer Research: Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Research, 2007.
117. Gonźalez C, Ńajera O, et al.: Hydrogen peroxide-induced DNA damage and DNA repair in lymphocytes from malnourished children. Environ Mol Mutagen 39, 33-42, 2002.
118. Ortiz R, Cortes E, et al.: Micronucleus frequency in spleen lymphocytes from severely malnourished rats during lactation. Environ Mol Mutagen 26, 55-59, 1995.
119. Key TJ, Appleby PN, et al.: Health effects of vegetarian and vegan diets. Proc Nutr Soc 65, 35-41, 2006.
120. Hunt JR: Bioavailability of iron, zinc, and other trace minerals from vegetarian diets. Am J Clin Nutr 78, 633S-639S, 2003.
121. Zhang ZF, Kurtz RC, et al.: Adenocarcinomas of the esophagus and gastric cardia: medical conditions, tobacco, alcohol, and socioeconomic factors. Cancer Epidemiol Biomarkers Prev 5, 761-768, 1996.
122. Lofvenberg E, Nordenson I, et al.:Cytogenetic abnormalities and leukemic transformation in hydroxyurea-treated patients with Philadelphia chromosome negative chronic myeloproliferative disease. Cancer Genet Cytogenet 49, 57-67, 1990.
123. Slupphaug G, Kavli B, et al. The interacting pathways for prevention and repair of oxidative DNA damage. Chem Biol Interact 531, 231-251, 2003. (Pubitemid 37456735)
124. Perentesis JP:Genetic predisposition and treatment-related leukemia. Med Pediatr Oncol 36, 541-548, 2001.
125. Payne CM, Holubec H, et al.: Crypt-restricted loss and decreased protein expression of cytochrome c oxidase subunit I as potential hypothesisdriven biomarkers of colon cancer risk. Cancer Epidemiol Biomarkers Prev 14, 2066-2075, 2005.
126. Oppenheimer SJ: Iron and its relation to immunity and infectious disease. J Nutr 131, 616S-635S, 2001.
127. Ahn JY, Nowell S, et al.: Associations between catalase phenotype and genotype: Modification by epidemiologic factors. Cancer Epidemiol Biomarkers Prev 15, 1217-1222, 2006.
128. Bai J and Cederbaum AI: Overexpression of catalase in the mitochondrial or cytosolic compartment increases sensitivity of HepG2 cells to tumor necrosis factor-alpha-induced apoptosis. J Biol Chem 275, 19241-19249, 2000.
129. Tatemichi M, Sawa T, et al.: Increased risk of intestinal type of gastric adenocarcinoma in Japanesewomen associated with long forms of CCTTT pentanucleotide repeat in the inducible nitric oxide synthase promoter. Cancer Lett 217, 197-202, 2005.